Chiral Technologies acquires Diffinity Genomics

chiralLogoWest Chester-based Chiral Technologies, part of DAICEL CORPORATION, the global market leader in enantioselective chromatography, is pleased to announce the acquisition of the assets of Diffinity Genomics® of West Henrietta, N.Y.

Diffinity Genomics has developed novel technology for the purification of nucleic acids, which formed the foundation for their products in DNA purification markets. The Diffinity RapidTip®technology provides a method for rapid purification of amplified DNA fragments from Polymerase Chain Reaction (PCR) in a single step.

“The innovative, patented purification technology from Diffinity was a perfect choice for our expansion in the bio-separation/purification marketspace,” commented Joseph Barendt, Ph.D., COO of Chiral Technologies, Inc.

As a new business unit of Chiral Technologies, Diffinity’s product portfolio demonstrates Chiral Technologies’ commitment to providing the health sciences industry with innovative separation technologies and ensures our customers will have access to new opportunities in DNA purification.

Click here to read more…


Leave a Reply

Website Survey

Need Help?

Please fill out the form below and we'll get back to you in two business days.

  • This field is for validation purposes and should be left unchanged.